Marker Therapeutics, Inc.(MRKR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRKR Marker Therapeutics, Inc.

休市中 11-22 16:00:00 EST

3.10

+0.15

+5.02%

盘后3.10

+0.000.00%

16:00 EST

最高3.23	最低2.91	成交量1.18万
今开2.96	昨收2.95	日振幅10.82%
总市值2,766万	流通市值2,096万	总股本892.27万
成交额3.58万	换手率0.17%	流通股本676.28万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRKR","market":"US","secType":"STK","nameCN":"Marker Therapeutics, Inc.","latestPrice":3.1,"timestamp":1732309200000,"preClose":2.9517,"halted":0,"volume":11802,"hourTrading":{"tag":"盘后","latestPrice":3.1,"preClose":3.1,"latestTime":"16:00 EST","volume":73,"amount":226.3,"timestamp":1732309201634},"delay":0,"floatShares":6762814,"shares":8922695,"eps":-1.088461,"marketStatus":"休市中","marketStatusCode":7,"change":0.1483,"latestTime":"11-22 16:00:00 EST","open":2.96,"high":3.23,"low":2.9105,"amount":35847.921169,"amplitude":0.108243,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.088461,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"adjPreClose":2.9517,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":3.1,"preClose":3.1,"latestTime":"16:00 EST","volume":73,"amount":226.3,"timestamp":1732309201634},"volumeRatio":0.386414,"impliedVol":5.7071,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/MRKR","defaultTab":"news","newsList":[{"id":"2485143892","title":"Marker Therapeutics, Inc.盘中异动 临近收盘快速上涨9.09%报3.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485143892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485143892?lang=zh_cn&edition=full","pubTime":"2024-11-23 04:59","pubTimestamp":1732309185,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日04时59分，Marker Therapeutics, Inc.股票出现异动，股价大幅上涨9.09%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123045945971a82c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123045945971a82c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","MRKR"],"gpt_icon":0},{"id":"2484692806","title":"Marker Therapeutics, Inc.盘中异动 股价大涨6.14%报3.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484692806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484692806?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:35","pubTimestamp":1732026939,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时35分，Marker Therapeutics, Inc.股票出现波动，股价急速上涨6.14%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.68%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223539971a76c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223539971a76c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRKR","BK4139"],"gpt_icon":0},{"id":"2484777456","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大涨5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484777456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484777456?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:51","pubTimestamp":1731945099,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时51分，Marker Therapeutics, Inc.股票出现波动，股价急速上涨5.86%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118235139abccd029&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118235139abccd029&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","BK4139","LENZ"],"gpt_icon":0},{"id":"2479039020","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大涨5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479039020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479039020?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:38","pubTimestamp":1730385507,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时38分，Marker Therapeutics, Inc.股票出现波动，股价急速拉升5.65%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.36%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031223828a2026bd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031223828a2026bd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","MRKR"],"gpt_icon":0},{"id":"2477371006","title":"Marker Therapeutics, Inc.盘中异动 股价大跌6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477371006","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477371006?lang=zh_cn&edition=full","pubTime":"2024-10-24 22:17","pubTimestamp":1729779437,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日22时17分，Marker Therapeutics, Inc.股票出现波动，股价大幅下跌6.34%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024221717a1e748f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024221717a1e748f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","BK4139","LENZ"],"gpt_icon":0},{"id":"2477952778","title":"Marker Therapeutics, Inc.盘中异动 股价大涨5.68%报3.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477952778","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477952778?lang=zh_cn&edition=full","pubTime":"2024-10-22 00:35","pubTimestamp":1729528510,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日00时35分，Marker Therapeutics, Inc.股票出现波动，股价快速拉升5.68%。截至发稿，该股报3.72美元/股，成交量7854股，换手率0.09%，振幅6.08%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102200351098e3d956&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102200351098e3d956&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRKR","BK4139"],"gpt_icon":0},{"id":"2475992482","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大涨6.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475992482","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475992482?lang=zh_cn&edition=full","pubTime":"2024-10-16 21:31","pubTimestamp":1729085491,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日21时31分，Marker Therapeutics, Inc.股票出现波动，股价快速拉升6.42%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410162131319f47d1bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410162131319f47d1bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MRKR","LENZ"],"gpt_icon":0},{"id":"2475268501","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大跌5.31%报3.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475268501","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475268501?lang=zh_cn&edition=full","pubTime":"2024-10-15 21:38","pubTimestamp":1728999516,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日21时38分，Marker Therapeutics, Inc.股票出现异动，股价急速下跌5.31%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015213836971a05f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015213836971a05f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRKR","BK4139"],"gpt_icon":0},{"id":"2472957963","title":"Marker Therapeutics, Inc.盘中异动 早盘大幅拉升10.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472957963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472957963?lang=zh_cn&edition=full","pubTime":"2024-10-04 21:34","pubTimestamp":1728048875,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日21时34分，Marker Therapeutics, Inc.股票出现波动，股价急速拉升10.42%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100421343698e3a955&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100421343698e3a955&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRKR","BK4139"],"gpt_icon":0},{"id":"2469491077","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大涨6.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469491077","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469491077?lang=zh_cn&edition=full","pubTime":"2024-09-24 21:30","pubTimestamp":1727184648,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日21时30分，Marker Therapeutics, Inc.股票出现异动，股价快速拉升6.92%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924213048ab65a51a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924213048ab65a51a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MRKR"],"gpt_icon":1},{"id":"2460600277","title":"Marker Therapeutics, Inc.盘中异动 早盘大幅上涨8.03%报3.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460600277","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460600277?lang=zh_cn&edition=full","pubTime":"2024-08-20 22:01","pubTimestamp":1724162491,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日22时01分，Marker Therapeutics, Inc.股票出现波动，股价急速上涨8.03%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820220131a1d53c85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820220131a1d53c85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MRKR"],"gpt_icon":0},{"id":"2459140703","title":"Marker Therapeutics, Inc.盘中异动 临近收盘股价大跌5.41%报3.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459140703","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459140703?lang=zh_cn&edition=full","pubTime":"2024-08-16 04:17","pubTimestamp":1723753030,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日04时17分，Marker Therapeutics, Inc.股票出现异动，股价急速跳水5.41%。截至发稿，该股报3.18美元/股，成交量3.8794万股，换手率0.43%，振幅9.22%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.25%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081604171097198de4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081604171097198de4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","BK4139","LENZ"],"gpt_icon":0},{"id":"2458998549","title":"Marker Therapeutics, Inc.盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458998549","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458998549?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:36","pubTimestamp":1723469785,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时36分，Marker Therapeutics, Inc.股票出现波动，股价快速拉升5.12%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812213626aefe6b02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812213626aefe6b02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MRKR","LENZ"],"gpt_icon":0},{"id":"2457345985","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大涨5.54%报4.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457345985","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457345985?lang=zh_cn&edition=full","pubTime":"2024-08-08 23:41","pubTimestamp":1723131661,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日23时41分，Marker Therapeutics, Inc.股票出现波动，股价大幅拉升5.54%。截至发稿，该股报4.00美元/股，成交量199股，换手率0.00%，振幅0.00%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为3.19%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080823410195893e0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080823410195893e0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","MRKR"],"gpt_icon":0},{"id":"2457755867","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457755867","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457755867?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:38","pubTimestamp":1722865132,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时38分，Marker Therapeutics, Inc.股票出现波动，股价快速下挫5.24%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.94%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052138529f10737a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052138529f10737a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRKR","BK4139"],"gpt_icon":0},{"id":"2456281391","title":"Marker Therapeutics, Inc.盘中异动 早盘大幅跳水6.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456281391","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456281391?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:36","pubTimestamp":1722605799,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时36分，Marker Therapeutics, Inc.股票出现异动，股价急速下跌6.40%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080221363995780f39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080221363995780f39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRKR","BK4139"],"gpt_icon":0},{"id":"2453588488","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大涨7.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453588488","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453588488?lang=zh_cn&edition=full","pubTime":"2024-07-24 23:20","pubTimestamp":1721834420,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日23时20分，Marker Therapeutics, Inc.股票出现异动，股价急速上涨7.02%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724232022af93ea4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724232022af93ea4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","BK4139","LENZ"],"gpt_icon":0},{"id":"2453999737","title":"Marker Therapeutics, Inc.盘中异动 股价大跌6.24%报4.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453999737","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453999737?lang=zh_cn&edition=full","pubTime":"2024-07-22 22:41","pubTimestamp":1721659304,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日22时41分，Marker Therapeutics, Inc.股票出现异动，股价急速下跌6.24%。截至发稿，该股报4.73美元/股，成交量2488股，换手率0.03%，振幅4.74%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722224144aefacc0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722224144aefacc0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRKR","BK4139"],"gpt_icon":0},{"id":"2451990208","title":"Marker Therapeutics, Inc.盘中异动 早盘大幅上涨7.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451990208","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451990208?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:53","pubTimestamp":1721137982,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时53分，Marker Therapeutics, Inc.股票出现异动，股价大幅拉升7.36%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716215302af9299c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716215302af9299c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MRKR","LENZ"],"gpt_icon":0},{"id":"2450534952","title":"Marker Therapeutics, Inc.盘中异动 大幅拉升7.57%报5.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450534952","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450534952?lang=zh_cn&edition=full","pubTime":"2024-07-12 22:35","pubTimestamp":1720794953,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日22时35分，Marker Therapeutics, Inc.股票出现异动，股价大幅上涨7.57%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.84%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712223553af921f44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712223553af921f44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.markertherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0098},{"period":"1month","weight":-0.3126},{"period":"3month","weight":-0.1542},{"period":"6month","weight":-0.2512},{"period":"1year","weight":0.1567},{"period":"ytd","weight":-0.4364}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Marker Therapeutics, Inc.是一家临床阶段的免疫肿瘤学公司，专门开发下一代T细胞免疫疗法，用于治疗血液系统恶性肿瘤和实体肿瘤适应症。 Marker的细胞治疗技术基于非工程化的肿瘤特异性T细胞的选择性扩增，其识别肿瘤相关抗原（即肿瘤靶标）并杀死表达这些靶标的肿瘤细胞。一旦输入患者，这组T细胞攻击多个肿瘤靶标并起到激活患者免疫系统的作用，以产生广谱抗肿瘤活性。由于Marker不对其T细胞进行基因工程改造，因此与目前基于CAR-T和TCR的工程方法相比，其产品（i）的成本更低，更容易制造，（ii）毒性明显降低，（ iii）与有意义的临床益处相关。因此，与当前基因修饰的CAR-T和基于TCR的疗法相比，Marker认为其T细胞疗法组合具有引人注目的治疗产品特征。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.027161},{"month":2,"riseRate":0.375,"avgChangeRate":-0.06492},{"month":3,"riseRate":0.5,"avgChangeRate":-0.065853},{"month":4,"riseRate":0.375,"avgChangeRate":0.001238},{"month":5,"riseRate":0.5,"avgChangeRate":0.232573},{"month":6,"riseRate":0.625,"avgChangeRate":0.292775},{"month":7,"riseRate":0.125,"avgChangeRate":-0.07757},{"month":8,"riseRate":0.375,"avgChangeRate":0.002117},{"month":9,"riseRate":0.25,"avgChangeRate":-0.071254},{"month":10,"riseRate":0.375,"avgChangeRate":-0.038018},{"month":11,"riseRate":0.25,"avgChangeRate":-0.097836},{"month":12,"riseRate":0.25,"avgChangeRate":0.056297}],"exchange":"NASDAQ","name":"Marker Therapeutics, Inc.","nameEN":"Marker Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Marker Therapeutics, Inc.(MRKR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Marker Therapeutics, Inc.(MRKR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Marker Therapeutics, Inc.,MRKR,Marker Therapeutics, Inc.股票,Marker Therapeutics, Inc.股票老虎,Marker Therapeutics, Inc.股票老虎国际,Marker Therapeutics, Inc.行情,Marker Therapeutics, Inc.股票行情,Marker Therapeutics, Inc.股价,Marker Therapeutics, Inc.股市,Marker Therapeutics, Inc.股票价格,Marker Therapeutics, Inc.股票交易,Marker Therapeutics, Inc.股票购买,Marker Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Marker Therapeutics, Inc.(MRKR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Marker Therapeutics, Inc.(MRKR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}